Efficacy and Safety of Implantable Cardioverter-Defibrillator Use in Peripartum Cardiomyopathy
In this cohort of patients with PPCM and ICD, rates of appropriate device therapy were high. Over long-term follow-up, rates of inappropriate shocks and device complications were also substantial in both PPCM and NICM cohorts.
Authors
- Melinda B. Davis (ORCID: https://orcid.org/0000-0002-3676-1982)
- Jasneet Devgun (ORCID: https://orcid.org/0000-0002-2330-2293)
- Auras R. Atreya (ORCID: https://orcid.org/0000-0002-4265-8738)
- Madeline Mahowald (ORCID: https://orcid.org/0000-0003-1685-6690)
- Heather Wheat (ORCID: https://orcid.org/0000-0001-5543-5990)
- Thomas Crawford (ORCID: https://orcid.org/0000-0003-4113-3371)
- Michael Ghannam (ORCID: https://orcid.org/0000-0001-6951-5238)
- Andrew B. Hughey (ORCID: https://orcid.org/0000-0001-7099-5478)
- Angelina Noll
- Josh Errickson
Institutions
- Trinity Health (US)
- University of Louisville (US)
- University of Michigan (US)
- Jacksonville University (US)
- Michigan Medicine (US)
- Institute for Social Research (NO)
- University of Florida Health Science Center (US)
- Florida College (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101827
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00